License Compliance definition

License Compliance. (This section shall replace section 10.5 of the End User License Agreement).
Sample 1Sample 2
License Compliance if You are a business, company or organization, You agree that upon request from CSS You will within thirty (30) days document and certify that the use of any and all CSS Software at the time of the request is in conformity with Your valid Software License Agreement. Discontinuing or Modifying Services: You acknowledge that CSS has the right to discontinue the manufacture and development of any of the Software and the support for that Software, in its sole discretion at any time, including the distribution of older Software versions. Notwithstanding the foregoing, if CSS discontinues the manufacture and support for a specific Software, Support for any remaining Software covered by this Agreement shall not be adversely affected. CSS reserves the right to alter the AMS services, in its sole discretion but in no event, shall such alterations result in: (a) diminished support from the level of support set forth herein; (b) materially diminished obligations for CSS; or (c) Your materially diminished rights. Governing Law: this Agreement will be governed by and construed in accordance with the laws of the State of Nevada, USA. The United Nations Convention on Contracts for the International Sale of Goods will not apply. You and CSS agree to submit to the exclusive jurisdiction of, and venue in, the courts in Las Vegas, Nevada, in any dispute arising out of or relating to this Agreement.
Sample 1
License Compliance if You are a business, company or organization, You agree that upon request from CSS You will within thirty (30) days document and certify that the use of any and all CSS Software at the time of the request is in conformity with Your valid Software License Agreement. Discontinuing or Modifying Services: You acknowledge that CSS has the right to discontinue the manufacture and development of any of the Software and the support for that Software, in its sole discretion at any time, including the distribution of older Software versions. Notwithstanding the foregoing, if CSS discontinues the manufacture and support for a specific Software, Support for any remaining Software covered by this Agreement shall not be adversely affected. CSS reserves the right to alter the AMS services, in its sole discretion but in no event, shall such alterations result in: (a) diminished support from the level of support set forth herein;
Sample 1

Examples of License Compliance in a sentence

  • Licensor or an Auditor (as defined below) has the right to verify Licensee’s compliance with this License Agreement (and please see Micro Focus License Compliance Charter - xxxx://xxxxxxxxxxx.xxxxxxxxxx.xxx/licensing/licVerification.aspx).

  • SLEEP MODE The desired room temperature is maintained quietly at lower fan speed.

  • R., De Paoli, S., D’Andrea, V., Weiss, M.: License Compliance Issues in Free and Open Source Soft- ware.

  • Licensor or an Auditor (as defined below) has the right to verify Licensee’s compliance with the licenses issued under Product Orders, the applicable ALAs and this Agreement (please see Micro Focus License Compliance Charter at xxxx://xxxxxxxxxxx.xxxxxxxxxx.xxx/licensing/licVerification.aspx, which can also be provided by Licensor at Licensee’s request).

  • The detailed subcategories of requirements for License Compliance of FLOSS components are demon- strated in Table 4.

  • Identification Information collected by the License Compliance Technology includes geographic location data, usernames, e-mail addresses, IP addresses, hostname, MAC addresses, and the domains from which the use of the Program(s) originated.

  • If the License Compliance Dispute is not resolved at the conclusion of Consultation, or if, in the event of noncompliance, the Licensee has not cured the failure within the established time, any Party may petition or otherwise request FERC to enforce the license article with which the Licensee is alleged to have failed to comply.

  • Licensor or an Auditor (as defined below) has the right to verify Licensee’s compliance with this License Agreement (and please see Micro Focus License Compliance Charter - http://supportline.microfocus.com/licensing/licVerification.aspx).

  • OrganizationPhoneE-mail / WebsiteCity of Cambridge Attn: Business License Compliance Officer Office of the City ClerkPO Box 669, 50 Dickson St.Cambridge, Ontario N1R 5W8 519-740-4680 ext.

  • Licensee is aware that Licensor may embed the Program(s) with third-party license compliance technology (“License Compliance Technology”) that reports information to both the third-party licensor of the License Compliance Technology (“Technology Provider”) and Licensor relating to unique user and network identification with respect to the use of the Program(s) (including, but not limited to, user names, e-mail addresses, IP addresses and the domains from which the use of the Program(s) originated).


More Definitions of License Compliance

License Compliance. If You are a business, company or organization, You agree that upon request from CSS You will within thirty (30) days document and certify that the use of any and all CSS Software at the time of the request is in conformity with Your valid Software License Agreement.
Sample 1

Related to License Compliance

  • LEGAL COMPLIANCE This Agreement and any transaction with, or payment to, you pursuant to the terms hereof is conditioned on your representation to us that, as of the date of this Agreement you are, and at all times during its effectiveness you will be, a bank as defined in Section 3(a)(6) of the Securities Exchange Act of 1934 (or other financial institution) and not otherwise required to register as a broker or dealer under such Act. You agree to notify us promptly in writing if this representation ceases to be true. You also agree that, regardless of whether you are a member of the NASD, you will comply with the rules of the NASD, including, in particular, Sections 2310, IM 2310-2, and 2830 of the NASD Conduct Rules, and that you will maintain adequate records with respect to your customers and their transactions, and that such transactions will be without recourse against you by your customers. We recognize that, in addition to applicable provisions of state and federal securities laws, you may be subject to the provisions of the Xxxxx-Xxxxxxxx Act and other laws governing, among other things, the conduct of activities by federal and state chartered and supervised financial institutions and their affiliated organizations. As such, you may be restricted in the activities that you may undertake and for which you may be paid, and, therefore, we recognize that you will not perform activities that are inconsistent with your statutory and regulatory obligations. Because you will be the only one having a direct relationship with the customer, you will be responsible in that relationship for insuring compliance with all laws and regulations, including those of all applicable federal and state regulatory authorities and bodies having jurisdiction over you or your customers to the extent applicable to securities purchases hereunder.

  • Year 2000 Compliance has the meaning set forth in section 17.29 of the Management Agreement.

  • Compliance Review means an inspection of the home, grounds, and files to determine compliance with these regulations.

  • Export Compliance You acknowledge that Licensor’s products and/or technology are subject to the U.S. Export Administration Regulations (the “EAR”) and You agree to comply with the EAR. You will not export or re-export Licensor’s products, directly or indirectly, to: (1) any countries that are subject to US export restrictions; (2) any end user who You know or have reason to know will utilize Licensor’s products in the design, development or production of nuclear, chemical or biological weapons, or rocket systems, space launch vehicles, and sounding rockets, or unmanned air vehicle systems, except as authorized by the relevant government agency by regulation or specific license; or (3) any end user who has been prohibited from participating in the US export transactions by any federal agency of the US government. By downloading or using the Software, You are agreeing to the foregoing and You are representing and warranting that You are not located in, under the control of, or a national or resident of any such country or on any such list. In addition, You are responsible for complying with any local laws in Your jurisdiction which may impact Your right to import, export or use Licensor’s products. Please consult the Bureau of Industry and Security web page xxx.xxx.xxx.xxx before exporting items subject to the EAR. For more information on exporting Software, including the applicable Export Control Classification Number (ECCN) and associated license exception (as applicable), see xxx.xxxx.xxx/xxxxxxx/xxxxx/. Upon request, Licensor's International Trade Services Department can provide information regarding applicable export restrictions for Licensor products. Licensor assumes no responsibility for Your failure to obtain any necessary export approvals. U.S. Government Restricted Rights. Use, duplication, or disclosure of any Deliverables by the U.S. Government is subject to the restrictions in FAR 52.227-14 (Dec 2007) Alternate III (Dec 2007), FAR 52.227-19 (Dec 2007), or DFARS 252.227-7013(b)(3) (Nov 1995), or applicable successor clauses.

  • Labor compliance agreement means an agreement entered into between a contractor or subcontractor and an enforcement agency to address appropriate remedial measures, compliance assistance, steps to resolve issues to increase compliance with the labor laws, or other related matters.

  • Assessment of Compliance As defined in Section 3.21.

  • Non-Compliance means failure/refusal to comply the terms and conditions of the tender;

  • major non-compliance outcome notification means a notification received by a council under section 19N(3) or (4) of the Food Act 1984, or advice given to council by an authorized officer under that Act, of a deficiency that does not pose an immediate serious threat to public health but may do so if no remedial action is taken

  • Safety compliance facility means a licensee that is a commercial entity that receives marihuana from a marihuana facility or registered primary caregiver, tests it for contaminants and for tetrahydrocannabinol and other cannabinoids, returns the test results, and may return the marihuana to the marihuana facility.

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Web Site Accessibility Standards/Specifications means standards contained in Title 1 Texas Administrative Code Chapter 206.

  • Diagnostic clinical procedures manual means a collection of written procedures that describes each method (and other instructions and precautions) by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration.

  • Quality Improvement means a focus on activities to improve performance above minimum standards and reasonably expected levels of performance, quality and practice.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Collaborative pharmacy practice agreement means a written and signed

  • Quality improvement organization or “QIO” shall mean the organization that performs medical peer review of Medicaid claims, including review of validity of hospital diagnosis and procedure coding information; completeness, adequacy and quality of care; appropriateness of admission, discharge and transfer; and appropriateness of prospective payment outlier cases. These activities undertaken by the QIO may be included in a contractual relationship with the Iowa Medicaid enterprise.

  • cGMP means current Good Manufacturing Practices as specified in the United States Code of Federal Regulations, ICH Guideline Q7A, or equivalent laws, rules, or regulations of an applicable Regulatory Authority at the time of manufacture.